Medinice Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Sanjeev Choudhary

Algemeen directeur

zł449.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	23.4%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	1.9yrs

Recente managementupdates

Recent updates

CEO

Sanjeev Choudhary

no data

Tenure

zł449,000

Compensatie

Mr. Sanjeev Choudhary serves as President of the Management Board and Chief Executive Officer at Medinice S.A. He also serves as Chairman at Medi Ventures Sp z o.o. and Medtech Innovation Center ASI SP z o...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Michael Glikson	Member of Scientific Board	1.9yrs	geen gegevens	geen gegevens
Agnieszka Rosinska	Member of the Supervisory Board	no data	zł18.00k	0.031% PLN 16.0k
Piotr Suwalski	Member of the Scientific Board	no data	geen gegevens	7.31% PLN 3.8m
Joanna Bogdanska	Chairwoman of the Supervisory Board	no data	zł27.00k	0.031% PLN 16.0k
Bogdan Szymanowski	Member of the Supervisory Board	no data	zł18.00k	0.21% PLN 111.1k
Wojciech Wróblewski	Member of the Supervisory Board	no data	zł18.00k	0.093% PLN 48.1k
Paul Grundeman	Member of the Scientific Board	no data	geen gegevens	geen gegevens
Pawel Balsam	Member of Scientific Board	less than a year	geen gegevens	geen gegevens
Adam Budzikowski	Member of the Scientific Board	3.4yrs	geen gegevens	geen gegevens
Marcin Golebicki	Member of the Supervisory Board	no data	zł18.00k	geen gegevens
Valavanur A. Subramanian	Member of Scientific Board	1.9yrs	geen gegevens	geen gegevens

1.9yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van ICE wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.9 jaar), wat duidt op een nieuw bestuur.

Medinice Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Medinice S.A., Annual General Meeting, Jun 26, 2024

Medinice S.A., Annual General Meeting, Jun 22, 2023

Medinice S.A., Annual General Meeting, Jun 22, 2022

Recent updates

Second quarter 2024 earnings released: zł0.18 loss per share (vs zł0.25 loss in 2Q 2023)

Will Medinice (WSE:ICE) Spend Its Cash Wisely?

New minor risk - Share price stability

Medinice S.A., Annual General Meeting, Jun 26, 2024

New major risk - Financial position

Full year 2023 earnings released: zł0.79 loss per share (vs zł0.79 loss in FY 2022)

Medinice S.A. to Report Q1, 2024 Results on May 09, 2024

Third quarter 2023 earnings released: zł0.20 loss per share (vs zł0.18 loss in 3Q 2022)

New minor risk - Share price stability

First half 2023 earnings released: zł0.43 loss per share (vs zł0.33 loss in 1H 2022)

New minor risk - Shareholder dilution

Here's Why We're Not Too Worried About Medinice's (WSE:ICE) Cash Burn Situation

Medinice S.A., Annual General Meeting, Jun 22, 2023

Medinice S.A. to Report Q3, 2023 Results on Nov 09, 2023

We're Hopeful That Medinice (WSE:ICE) Will Use Its Cash Wisely

Second quarter 2022 earnings released: zł0.17 loss per share (vs zł0.20 loss in 2Q 2021)

Medinice S.A., Annual General Meeting, Jun 22, 2022

First quarter 2022 earnings released: zł0.16 loss per share (vs zł0.075 loss in 1Q 2021)

An unknown buyer entered into an agreement to acquire Medi Ventures Sp. z o.o. from Medinice S.A. (WSE:ICE).

Second quarter 2021 earnings released: zł0.21 loss per share (vs zł0.04 loss in 2Q 2020)

Medinice S.A. announced that it has received PLN 24.89298 million in funding

Medinice S.A. (WSE:ICE) agreed to acquire 40% stake in JitMed for PLN 2.1 million.

Medinice S.A. announced a financing transaction

Full year 2020 earnings released: zł0.56 loss per share (vs zł0.52 loss in FY 2019)

New 90-day high: zł24.80

Medinice S.A. to Report First Half, 2021 Results on Sep 21, 2021

New 90-day high: zł23.80

Medinice S.A. announced a financing transaction

New 90-day low: zł14.50

New 90-day high - zł19.50

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur